February 2018 FDA Recall Evamist by Paddock Laboratories, Llc.
D-0608-2018 - Defective Delivery System

This Class II drug recall was voluntarily initiated by Paddock Laboratories, Llc. on February 26, 2018 for the product Evamist. The FDA reported the reason for recall as defective delivery system. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0608-2018

Reason for Recall
Defective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense product.
Initiated
02-26-2018
Reported
04-04-2018
Quantity
52,596 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Paddock Laboratories, LLC.
Nationwide within the USA.
Evamist (estradiol transdermal spray), 1.53mg estradiol/spray, 0.27 fl oz (8.1 mL) per bottle, Rx Only, Manufactured for Perrigo, Minneapolis, MN 55427. NDC: 0574-2067-27

Batch or Lot Expiration Information

Lot# Lot: MEEF Exp. 04/2020

Affected Packages Involved in this Recall